Trulieve Cannabis (TRLV) Debt to Equity (2020 - 2026)

Trulieve Cannabis (TRLV) has reported Debt to Equity for 7 consecutive years, with $0.08 the latest figure, recorded in Q1 2026.

• In Q1 2026, Debt to Equity fell 14.02% year-over-year to $0.08; the TTM figure through Mar 2026 stood at $0.08 (down 14.02% YoY), while the FY2025 annual figure was $0.08, down 11.33% from the prior year.
• Debt to Equity came in at $0.08 for Q1 2026 at Trulieve Cannabis, down from $0.08 in the prior quarter.
• The five-year high for Debt to Equity was $0.09 in Q1 2025, with the low at $0.01 in Q1 2022.
• Average Debt to Equity over 5 years is $0.07, with a median of $0.08 recorded in 2025.
• Across the five-year window, Debt to Equity jumped 637.45% in 2022 and slipped 14.02% in 2026, its largest moves.
• Year by year, Debt to Equity stood at $0.07 in 2022, then grew by 22.99% to $0.08 in 2023, then climbed by 8.97% to $0.09 in 2024, then dropped by 11.33% to $0.08 in 2025, then dropped by 1.35% to $0.08 in 2026.
• According to Business Quant data, Debt to Equity over the past three periods registered $0.08, $0.08, and $0.09 for Q1 2026, Q4 2025, and Q3 2025 respectively.